Eclinicalmedicine
- All
- News
-
Long-Covid Patients Continue To Struggle With Brain Function For At Least Two Years: Study
- Sunday July 30, 2023
- Feature | Edited by Anjali Thakur
The neurological symptoms include brain fog, numbness, tingling, headache, dizziness, blurred vision, tinnitus and fatigue.
- www.ndtv.com
-
Blood Thinners Reduce Covid Deaths By 50%, Hospitalisation By 43%: US Study
- Monday October 4, 2021
- World News | Press Trust of India
Covid patients who use blood thinners may have a nearly 50% reduced risk of death and a 43% lower risk of hospitalisation, according to a study published in Lancet's EClinicalMedicine journal.
- www.ndtv.com
-
Monoclonal Antibody Treatment Combo Cuts Hospitalisation Among High-Risk Covid Patients: Study
- Tuesday August 31, 2021
- World News | Press Trust of India
A combination of 2 monoclonal antibody treatments keeps high-risk Covid patients out of the hospital when infected with mild to moderate disease, according to an observational study published in The Lancet's EClinicalMedicine journal.
- www.ndtv.com
-
Long-Covid Patients Continue To Struggle With Brain Function For At Least Two Years: Study
- Sunday July 30, 2023
- Feature | Edited by Anjali Thakur
The neurological symptoms include brain fog, numbness, tingling, headache, dizziness, blurred vision, tinnitus and fatigue.
- www.ndtv.com
-
Blood Thinners Reduce Covid Deaths By 50%, Hospitalisation By 43%: US Study
- Monday October 4, 2021
- World News | Press Trust of India
Covid patients who use blood thinners may have a nearly 50% reduced risk of death and a 43% lower risk of hospitalisation, according to a study published in Lancet's EClinicalMedicine journal.
- www.ndtv.com
-
Monoclonal Antibody Treatment Combo Cuts Hospitalisation Among High-Risk Covid Patients: Study
- Tuesday August 31, 2021
- World News | Press Trust of India
A combination of 2 monoclonal antibody treatments keeps high-risk Covid patients out of the hospital when infected with mild to moderate disease, according to an observational study published in The Lancet's EClinicalMedicine journal.
- www.ndtv.com